Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06051942 · ClinicalTrials.gov registry record · NA
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
A NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer, sponsored by PROCEPT BioRobotics.
- Active
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 6
- Study locations
NCT06051942: Active NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer, sponsored by PROCEPT BioRobotics.
NCT06051942 is a NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer that is active but no longer recruiting, run by PROCEPT BioRobotics. The registered enrollment target is 125 participants, below the 548-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (77% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06051942, a NA study of Benign Prostatic Hyperplasia and Localized Prostate Cancer, is active but no longer recruiting, sponsored by PROCEPT BioRobotics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 6
- Study locations
Study Summary
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Primary Outcome
Proportion (percentage) of participants with adverse events rated as related to the study procedure classified as Clavien-Dindo Grade 2 or higher or any Grade 1 event resulting in persistent disability (ejaculatory disorder, erectile dysfunction, or incontinence) evidenced through 3 months post-treatment.
Conditions Studied
Interventions
- DEVICE Robotic Waterjet Treatment
Study Locations (6)
Other
- The Chinese University of Hong Kong - Hong Kong
- American University of Beirut - Beirut
- Tauranga Urology Research Ltd - Tauranga
California
- San Diego Clinical Trials - La Mesa
Illinois
- Endeavour Health (NorthShore University HealthSystem) - Glenview
Virginia
- Potomac Urology Center - Alexandria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2022-11-22 |
| Est. Completion | 2027-03 |
| Phase | NA |
What the registry record for NCT06051942 still lists
NCT06051942 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 548-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Robotic Waterjet Treatment is the first listed.
NCT06051942 lists 6 locations in 4 states (Other, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT06051942 about?
NCT06051942 is a clinical study titled "PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs". The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline...
What is the current status of trial NCT06051942?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2022-11-22. Estimated completion is 2027-03.
What conditions does trial NCT06051942 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Localized Prostate Cancer.
What interventions are being tested in trial NCT06051942?
The interventions under investigation include: Robotic Waterjet Treatment (DEVICE).
Who is sponsoring clinical trial NCT06051942?
This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06051942 being conducted?
This trial has 6 study locations across California, Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06051942's enrollment target sits among peer trials
125 17th of 29 higher than 13 of 29 other Benign Prostatic Hyperplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Benign Prostatic Hyperplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI